GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Budrul Chukrut | Lightrocket | Getty ImagesGlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company's new RSV vaccine to start off slower than it did for its blockbuster shingles shot.But she is confident that…